First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group
Authors:
- A ColaoA Colao
- P CappabiancaPCP Cappabianca
- R CozziRCR Cozzi
- A.L.I.C.E. Study GroupAGA.L.I.C.E. Study Group
- 1 December 2006
- journal article
- manifesto
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 29 (11) , 1017-1020
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Predictors of Tumor Shrinkage after Primary Therapy with Somatostatin Analogs in Acromegaly: A Prospective Study in 99 PatientsThe Journal of Clinical Endocrinology & Metabolism, 2006
- Gamma knife radiosurgery for acromegaly – long‐term experienceClinical Endocrinology, 2006
- Primary Treatment of Acromegaly with Octreotide LAR: A Long-Term (Up to Nine Years) Prospective Study of Its Efficacy in the Control of Disease Activity and Tumor ShrinkageThe Journal of Clinical Endocrinology & Metabolism, 2006
- Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitisEuropean Journal of Endocrinology, 2006
- Partial Surgical Removal of Growth Hormone-Secreting Pituitary Tumors Enhances the Response to Somatostatin Analogs in AcromegalyThe Journal of Clinical Endocrinology & Metabolism, 2006
- Consensus statement: medical management of acromegalyEuropean Journal of Endocrinology, 2005
- Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to PegvisomantThe Journal of Clinical Endocrinology & Metabolism, 2005
- Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin statusClinical Endocrinology, 2004
- Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experienceClinical Endocrinology, 1999
- The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenomaClinical Endocrinology, 1998